Websites targeting keyword nsclc
15 websites are using keyword nsclc in their content.
Total results: 15
Domains on this page: 15
Results:
For Healthcare Professionals | CYRAMZA® (ramucirumab)http://portalrankings.com/info/cyramzahcp.com
CYRAMZA, combined with other medications, is used for the treatment of patients with advanced gastric cancer or GEJ, metastatic non-small cell lung cancer (NSCLC), and metastatic colorectal cancer (mCRC).
- Updated On (Date): 2016-Aug-23
- Expiration time: 2017-Aug-27
- Website Registered On (Date): 2013-Aug-27
Treatment for certain lung, stomach, and colorectal tumors | CYRAMZA(R) (ramucirumab)http://portalrankings.com/info/cyramza.com
CYRAMZA® (ramucirumab), combined with other medications, is used for the treatment of patients with metastatic non-small cell lung cancer (NSCLC), advanced gastric cancer, gastroesophageal junction (GEJ) cancer, and metastatic colorectal cancer (CRC).
- Updated On (Date): 2017-Oct-01
- Expiration time: 2018-Oct-05
- Website Registered On (Date): 2011-Oct-05
OPDIVO® (nivolumab) | Information for Healthcare Professionalshttp://portalrankings.com/info/opdivohcp.com
Learn more about OPDIVO® (nivolumab). Prescribed medication to treat certain types of cancers. Read about its indications, clinical data and efficacy.
- Updated On (Date): 2017-Feb-27
- Expiration time: 2018-Mar-03
- Website Registered On (Date): 2014-Mar-03
Clinton Essex Franklin Library Systemhttp://portalrankings.com/info/cefls.org
Welcome to the Clinton Essex Franklin Library System. You'll find information on public libraries and library resources in the Northeastern New York Region.
- Google Analytics code: 2076086-1
- Updated On (Date): 2017-Jan-20
- Expiration time: 2018-Jan-27
- Website Registered On (Date): 2000-Jan-27
GIOTRIF® (afatinib) - | Boehringer Ingelheimhttp://portalrankings.com/info/giotrif.com
GIOTRIF® (afatinib) -
- Google Analytics code: 44006287-1
- Updated On (Date): 2016-Jun-19
- Expiration time: 2018-Jun-20
- Website Registered On (Date): 2007-Jun-20
SITC Cancer Immunotherapy CONNECT - Society for Immunotherapy of Cancer (SITC)http://portalrankings.com/info/sitcancer.org
Cancer Immunotherapy CONNECT is the official website of the Society for Immunotherapy of Cancer (SITC), the world’s leading member-driven organization specifically dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy.
- Known AddThis user account ID: ra-586d5f6453e2f81d
- Google Analytics code: 93226076-1
- Updated On (Date): 2017-Jan-06
- Expiration time: 2025-Dec-13
- Website Registered On (Date): 2010-Dec-13
Homehttp://portalrankings.com/info/iressa.com
Official site of IRESSA (gefitinib), indicated in Europe for the treatment of adults with locally advanced or metastatic NSCLC with activating mutations of EGFR-TK across all lines of therapy.
- Updated On (Date): 2016-Aug-09
- Expiration time: 2017-Aug-13
- Website Registered On (Date): 1999-Aug-13
OPDIVO® (nivolumab) | Patient Gatewayhttp://portalrankings.com/info/opdivo.com
OPDIVO® (nivolumab) is a prescription medication. Read about its indications, side effects, and more.
- Updated On (Date): 2016-Nov-01
- Expiration time: 2017-Nov-06
- Website Registered On (Date): 2012-Nov-06
Law Offices of Steven I. Greene, ESQ. -- Personal Injury Attorneyhttp://portalrankings.com/info/injurylawnj.com
Our New Jersey accident attorneys represent the rights of people who have been seriously injured by negligence or misconduct, and we do not represent corporations, banks, or insurance companies.
- Google Analytics code: 12539584-11
- Updated On (Date): 2015-Sep-24
- Expiration time: 2020-Sep-23
- Website Registered On (Date): 2005-Dec-16
TAGRISSO™ (osimertinib) | Official Global Sitehttp://portalrankings.com/info/tagrisso.com
Learn more about TAGRISSO (osimertinib) and its benefits, side effects and efficacy for the treatment of patients with EGFRm T790M mutation-positive NSCLC.
- Updated On (Date): 2017-Apr-20
- Expiration time: 2018-Apr-24
- Website Registered On (Date): 2015-Apr-24
GIOTRIF® - Wirksamkeit und Anwendunghttp://portalrankings.com/info/giotrif.de
Wichtiges direkt vom Hersteller für Ärzte und Apotheker rund um den Einsatz von GIOTRIF®, den ersten irreversiblen ErbB-Family-Blocker für Patienten mit lokal fortgeschrittenem und / oder metastasiertem nicht-kleinzelligen Lungenkarzinom (NSCLC) mit aktivierenden EGFR-Mutationen.
- Google Analytics code: 47865526-1
- Updated On (Date): 2016-Aug-24
Law Office of Stephen J. Silverberg, PChttp://portalrankings.com/info/sjslawpc.com
- Google Analytics code: 225723-36
- Updated On (Date): 2011-Apr-28
- Expiration time: 2020-Oct-30
- Website Registered On (Date): 2009-Oct-30
Advanced NS NSCLC Treatment | ALIMTA (pemetrexed for injection)http://portalrankings.com/info/alimta.com
Learn how ALIMTA may help treat advanced nonsquamous non-small cell lung cancer (NSCLC). Find information about taking ALIMTA for the treatment of advanced NS NSCLC.
- Updated On (Date): 2017-Aug-13
- Expiration time: 2018-Aug-17
- Website Registered On (Date): 1999-Aug-17